Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/13/1994 | US5347075 Mutagenesis testing using transgenic non-human animals carrying test DNA sequences |
09/13/1994 | US5346999 Method of nucleic acid extraction |
09/13/1994 | US5346998 Artificial |
09/13/1994 | US5346994 Solvent extraction with phenol, guanidinium and thiocyanate |
09/13/1994 | US5346991 Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
09/13/1994 | US5346830 Gene expression system based on regulatory elements of bateriophage P2 and satellite phage P4 |
09/13/1994 | US5346825 Preventing adhesion to vessel walls |
09/13/1994 | US5346824 DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof |
09/13/1994 | US5346823 Subtilisin modifications to enhance oxidative stability |
09/13/1994 | US5346818 Method for the conjugative transfer of mobilizable vectors for E. coli to gram-positive bacteria and vectors suitable for use in such a method |
09/13/1994 | US5346815 Sodium ion binding proteins |
09/13/1994 | US5346672 Devices for containing biological specimens for thermal processing |
09/13/1994 | CA2118843A1 Use of lymphocytes transformed with herpesvirus saimiri on a process for replicating viruses of the hiv type which cause immune deficiency |
09/11/1994 | CA2118642A1 Bone-associated transcription control factor-like protein and process for producing the same |
09/10/1994 | CA2118558A1 Soluble human fc-gamma iii receptors, process for the preparation thereof, pharmaceutical compositions containing same, utilization thereof as medicaments, and diagnostic application thereof |
09/07/1994 | EP0613949A2 Gene encoding chondroitinase ABC and uses therefor |
09/07/1994 | EP0613947A2 Mitogenic factor, gene thereof and method of microdetection therefor |
09/07/1994 | EP0613946A2 hst-2 Mutein, DNA coding for the same and preparation thereof |
09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
09/07/1994 | EP0613899A2 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
09/07/1994 | EP0613501A1 Oligonucleotides and their use in an assay for encephalopathies. |
09/07/1994 | EP0613500A1 Membrane expression of heterologous genes |
09/07/1994 | EP0613499A1 Human il-4 mutant proteins |
09/07/1994 | EP0613498A1 Receptor derivates with binding sites for human rhinoviruses |
09/07/1994 | EP0613497A1 Lymphoid cd30-antigen. |
09/07/1994 | EP0613496A1 Collagen-like polypeptides |
09/07/1994 | EP0613495A1 Transgenic animals lacking prion proteins |
09/07/1994 | EP0462210B1 Vaccines for nontypable haemophilus influenzae |
09/07/1994 | EP0411033B1 Storage stable formulations of homogenous dimeric m-csf |
09/07/1994 | CN1091775A Marmoset zona pellucida protein ZP3 |
09/07/1994 | CN1091774A Ethanol production by recombinant hosts |
09/07/1994 | CN1091773A Recombinant mutant pastaurella multocida protein, process for preparing same, DNA sequence encoding the protein, replicon comprising the DNA sequence and cells transformed with such replicon |
09/07/1994 | CN1091583A Method for the production of proteins in plant fluids |
09/06/1994 | US5344923 Improved salt and drought resistance for plants |
09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
09/06/1994 | US5344777 Structural gene of membrane-bound alcohol dehydrogenase complex, plasmid containing the same and transformed acetic acid bacteria |
09/06/1994 | US5344776 DNA encoding an insect octopamine receptor |
09/06/1994 | US5344773 Human uterine tissue plasminogen activator produced by recombinant DNA |
09/06/1994 | US5344771 Plant thiosterases |
09/06/1994 | US5344765 Cercropin |
09/06/1994 | US5344764 Protein inhibitors of phospholipase A2 purified from inflammatory sites and production process |
09/06/1994 | US5344645 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
09/06/1994 | US5343773 Device for generating and decoupling different movements in cleaning and sealing stations in ink printers |
09/06/1994 | CA2116280A1 Huntingtin dna, protein and uses thereof |
09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
09/06/1994 | CA1331837C Tomatoes |
09/03/1994 | CA2116460A1 Preventive or therapeutic agents for alzheimer's disease, a screening method of alzheimer's disease and tau-protein kinase i originated from human being |
09/01/1994 | WO1994019495A1 Recombinant epstein-barr viral capsid antigen useful in diagnostic method |
09/01/1994 | WO1994019494A1 Inhibition of tax-mediated increase in dna binding |
09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
09/01/1994 | WO1994019488A1 Borrelia burgdorferi spirochaete-specific nucleic acid probes |
09/01/1994 | WO1994019482A1 Heterologous antigens in live cell vaccine strains |
09/01/1994 | WO1994019478A1 Production of high titer helper-free retroviruses by transient transfection |
09/01/1994 | WO1994019477A1 Geminivirus-based gene expression system |
09/01/1994 | WO1994019476A1 Plant virus resistance conferring polyribozyme and resistant plants producing same |
09/01/1994 | WO1994019475A2 Yeast agglutination genes and yeast containing them |
09/01/1994 | WO1994019474A1 Process for producing human growth hormone |
09/01/1994 | WO1994019473A1 Modulators of gene expression |
09/01/1994 | WO1994019472A2 Bi-functional expression system |
09/01/1994 | WO1994019471A1 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
09/01/1994 | WO1994019468A1 Dna fragment containing gene for alkaline pullulanase |
09/01/1994 | WO1994019467A1 Brazzein sweetener |
09/01/1994 | WO1994019466A2 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
09/01/1994 | WO1994019465A2 NOVEL DNA- BINDING REGULATOR OF c-myc EXPRESSION WHICH BINDS TO THE FAR UPSTREAM ELEMENTS (FUSE) AND cDNA THEREFOR |
09/01/1994 | WO1994019464A2 Human dna sequence encoding a kidney atp-dependent potassium channel |
09/01/1994 | WO1994019463A2 Developmental tyrosine kinases and their ligands |
09/01/1994 | WO1994019462A1 Harp family growth factors, preparation methods therefor and uses thereof |
09/01/1994 | WO1994019461A1 METHOD FOR IDENTIFYING COMPOUNDS THAT INDUCE AN INCREASED LEVEL OF THE NERVE GROWTH FACTOR mRNA |
09/01/1994 | WO1994019460A1 Bacteriophage ølc3-based vector system for transformation of bacteria |
09/01/1994 | WO1994019459A1 Method for obtaining an increased production of a producing celline by using a fusion protocol |
09/01/1994 | WO1994019457A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
09/01/1994 | WO1994019454A2 An amylolytic enzyme |
09/01/1994 | WO1994019364A2 Nucleic acid probes chemically 5'(oh)- and/or 3'(oh)-modified for inserting one or more non-radioactive labeling elements thereat, and method for preparing same |
09/01/1994 | WO1994019023A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
09/01/1994 | WO1994019022A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
09/01/1994 | WO1994019016A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
09/01/1994 | WO1994019015A1 Recombinant fowlpox viruses and uses thereof |
09/01/1994 | WO1994019014A1 Recombinant fowlpox virus s-fpv-043 and uses thereof |
09/01/1994 | WO1994019013A1 Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
09/01/1994 | WO1994018999A1 A mutant protein and methods and materials for making and using it |
09/01/1994 | WO1994018992A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |
09/01/1994 | WO1994018835A1 Treatment of androgen-associated baldness using antisense oligomers |
09/01/1994 | WO1994018834A1 Polyelectrolyte dna conjugation and genetic transformation of an animal |
09/01/1994 | WO1994016103A3 Detection of synthetic oligonucleotides extracted from body fluids or tissues |
09/01/1994 | WO1994016078A3 High lysine derivatives of alpha-hordothionin |
09/01/1994 | WO1994016069A3 Ras associated gap proteins |
09/01/1994 | WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides |
09/01/1994 | WO1994007432A3 Porous vascular implants |
09/01/1994 | WO1994006449A3 Morphogen-induced liver regeneration |
09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
09/01/1994 | CA2156850A1 Harp family growing factors, preparation methods and uses thereof |
09/01/1994 | CA2156725A1 Production of high titer helper-free retroviruses by transient transfection |
09/01/1994 | CA2156720A1 Geminivirus-based gene expression system |
09/01/1994 | CA2156635A1 Composition useful for the treatment of tumors and immunization of organisms against tumors |
09/01/1994 | CA2156525A1 Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
09/01/1994 | CA2156423A1 Recombinant fowlpox viruses and uses thereof |
09/01/1994 | CA2156302A1 An amylolytic enzyme |